HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pier Luigi Meroni Selected Research

Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)

3/2022Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction.
12/2021COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
6/2021Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies.
1/2021Anti-phospholipid antibodies and reproductive failures.
1/2021Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One.
1/2021Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome.
11/2020Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
10/2020Development of a certified reference material for anti-β2-glycoprotein I IgG - commutability studies.
9/2020Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester.
7/2020Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pier Luigi Meroni Research Topics

Disease

61Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
03/2022 - 07/2002
36Thrombosis (Thrombus)
01/2022 - 05/2003
30Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 03/2004
30Rheumatoid Arthritis
07/2020 - 01/2006
29Autoimmune Diseases (Autoimmune Disease)
01/2021 - 12/2002
18Inflammation (Inflammations)
08/2021 - 12/2002
13Rheumatic Diseases (Rheumatism)
01/2021 - 03/2010
11Systemic Scleroderma (Systemic Sclerosis)
11/2020 - 06/2002
9COVID-19
06/2022 - 01/2020
9Pregnancy Complications
01/2021 - 06/2006
8Spontaneous Abortion (Miscarriage)
12/2020 - 06/2016
7Atherosclerosis
12/2019 - 12/2002
6Hypertension (High Blood Pressure)
01/2019 - 12/2002
5Juvenile Arthritis (Juvenile Idiopathic Arthritis)
09/2021 - 04/2012
5Venous Thrombosis (Deep-Vein Thrombosis)
12/2019 - 01/2004
5Congenital heart block
01/2019 - 01/2003
5Necrosis
10/2018 - 07/2004
4Infections
03/2022 - 05/2014
4Thrombocytopenia (Thrombopenia)
01/2022 - 01/2004
4Arthritis (Polyarthritis)
05/2020 - 11/2010
4Atherosclerotic Plaque (Atheroma)
01/2017 - 12/2002
3Hemorrhage
10/2019 - 01/2014
3Pain (Aches)
01/2019 - 09/2008
3Neonatal Systemic lupus erythematosus
01/2019 - 12/2004
3Neoplasms (Cancer)
01/2018 - 03/2010
3Vasculitis (Vasculitides)
12/2017 - 01/2014
3Psoriatic Arthritis
08/2017 - 01/2017
3Connective Tissue Diseases (Connective Tissue Disease)
01/2017 - 01/2015
3Lupus Nephritis
11/2016 - 01/2004
3Communicable Diseases (Infectious Diseases)
11/2015 - 01/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2015 - 05/2014
3Cardiovascular Diseases (Cardiovascular Disease)
09/2013 - 03/2005
2Pre-Eclampsia (Preeclampsia)
01/2020 - 11/2016
2Pyoderma Gangrenosum
04/2018 - 12/2014

Drug/Important Bio-Agent (IBA)

51AntibodiesIBA
06/2022 - 06/2002
35Antiphospholipid AntibodiesIBA
01/2022 - 05/2003
28AutoantibodiesIBA
03/2022 - 06/2002
17Biomarkers (Surrogate Marker)IBA
06/2022 - 07/2004
16Immunoglobulin G (IgG)IBA
06/2022 - 11/2003
16Phospholipids (Phosphatides)FDA LinkGeneric
03/2022 - 07/2002
12Glycoproteins (Glycoprotein)IBA
01/2020 - 06/2006
11Complement System Proteins (Complement)IBA
11/2021 - 12/2012
10Biological ProductsIBA
01/2019 - 09/2009
9CytokinesIBA
12/2019 - 09/2012
7Antinuclear AntibodiesIBA
01/2021 - 02/2005
7Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2016 - 07/2002
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2007
6Pharmaceutical PreparationsIBA
05/2020 - 03/2010
6Adalimumab (Humira)FDA Link
05/2020 - 01/2006
5Tumor Necrosis Factor InhibitorsIBA
05/2020 - 08/2014
5Infliximab (Remicade)FDA Link
05/2020 - 09/2008
5Carrier Proteins (Binding Protein)IBA
12/2019 - 02/2007
5Hydroxychloroquine (Plaquenil)FDA LinkGeneric
10/2019 - 01/2016
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 01/2006
4InterferonsIBA
01/2021 - 12/2006
4Antirheumatic Agents (DMARD)IBA
01/2021 - 03/2018
4Immunoglobulin M (IgM)IBA
12/2020 - 01/2004
4EpitopesIBA
07/2020 - 02/2011
4Etanercept (Enbrel)FDA Link
05/2020 - 04/2012
4CholesterolIBA
01/2020 - 12/2002
4Peptides (Polypeptides)IBA
01/2019 - 07/2005
4AnticoagulantsIBA
01/2017 - 07/2004
4C-Reactive ProteinIBA
05/2016 - 06/2007
3belimumabIBA
01/2022 - 01/2018
3ChemokinesIBA
01/2022 - 09/2007
3Immunologic Factors (Immunomodulators)IBA
01/2022 - 08/2013
3Thromboplastin (Tissue Factor)IBA
12/2021 - 10/2007
3Proteins (Proteins, Gene)FDA Link
08/2021 - 09/2007
3Toll-Like Receptors (Toll-Like Receptor)IBA
11/2020 - 10/2007
3Antigen-Antibody Complex (Immune Complex)IBA
11/2020 - 12/2002
3Lipoproteins (Lipoprotein)IBA
07/2020 - 08/2013
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2019 - 06/2012
3Methotrexate (Mexate)FDA LinkGeneric
08/2018 - 08/2012
3InterleukinsIBA
01/2018 - 09/2008
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2017 - 01/2014
3PTX3 proteinIBA
01/2017 - 03/2010
3fibrin fragment D (D-dimer)IBA
05/2016 - 07/2004
3Interleukin-6 (Interleukin 6)IBA
05/2016 - 07/2004
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016 - 12/2002
3LipopolysaccharidesIBA
12/2014 - 10/2007
3Toll-Like Receptor 4IBA
08/2014 - 10/2007
3AntigensIBA
01/2014 - 06/2002
3Tissue Plasminogen Activator (Alteplase)FDA Link
02/2010 - 03/2004
2tocilizumab (atlizumab)FDA Link
01/2022 - 07/2020
2Platelet Factor 4IBA
01/2022 - 11/2021
2Messenger RNA (mRNA)IBA
01/2022 - 01/2018
2GlucocorticoidsIBA
01/2022 - 01/2021
2Oxygen (Dioxygen)IBA
01/2022 - 01/2021
2Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 10/2019
2VaccinesIBA
11/2021 - 03/2018
2Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2020 - 11/2020
2ImmunosorbentsIBA
10/2020 - 11/2015
2EnzymesIBA
10/2020 - 11/2015
2LipidsIBA
01/2020 - 03/2005
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2019 - 01/2018
2CoagulantsIBA
01/2019 - 02/2013
2Rituximab (Mabthera)FDA Link
07/2018 - 01/2011

Therapy/Procedure

21Therapeutics
01/2022 - 12/2002
3Biological Therapy
01/2021 - 06/2011
2Immunomodulation
01/2022 - 01/2021